Skip to main content
. 2021 Oct 1;8:726214. doi: 10.3389/fmed.2021.726214

Figure 1.

Figure 1

Significant different miRNA expressions in the urine or plasma between CKD and CKD + UC. (A) miRNA levels from the urine of patients detected by qRT-PCR using RNU6 as a control (n = 200). (B) miRNA levels from the plasma were detected by qRT-PCR using RNU6 as a control (n = 134). The Y axis presents the expression level (Log10 2-ΔCT). CKD, patients with chronic kidney disease. CKD+UC, the urothelial carcinoma patients with CKD. The p-value was analyzed by Student's t-test for each miRNA.